Survival of patients with aromatase inhibitors sensitive, HR1/HER2-metastatic breast cancer treated with a first-line endocrine therapy or chemotherapy in a multicenter national observational study

Affiliation auteursAffiliation ok
TitreSurvival of patients with aromatase inhibitors sensitive, HR1/HER2-metastatic breast cancer treated with a first-line endocrine therapy or chemotherapy in a multicenter national observational study
Type de publicationJournal Article
Year of Publication2017
AuteursJacquet E., Lardy-Cleaud A., Pistilli B., Cottu P., Delaloge S., Debled M., Vanlemmens L., Anne-Valerie G., Leheurteur M., Laborde L., Jacot W., Berchery D., Coudert B., Ferrero J-M., Parent D., Dieras V., Velten M., Courtinard C., Robain M., Bachelot T.
JournalANNALS OF ONCOLOGY
Volume28
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN0923-7534